Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Speech-Language Rehabilitation to Enhance Recovery in Patients Suffering From Broca's Aphasia, Following a Stroke.

NCT00170703 is registered in ClinicalTrials.gov with Northstar Neuroscience as lead sponsor.

NCT NCT00170703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Speech-Language Rehabilitation to Enhance Recovery in Patients Suffering From Broca's Aphasia, Following a Stroke.
Lead sponsor
Northstar Neuroscience
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2004
Completion date
September 30, 2007
Enrollment
8
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

broca's aphasia, stroke